Latest Breaking News On - Private placement purchaser - Page 1 : comparemela.com

Certain Common Stock of Lexicon Pharmaceuticals, Inc are subject to a Lock-Up Agreement Ending on 31-JUL-2023

Certain Common Stock of Lexicon Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 31-JUL-2023. These Common Stock will be under lockup for 60 days starting from 1-JUN-2023 to.

Citigroup global markets incCertain common stock of lexicon pharmaceuticals incCertain common stockLexicon pharmaceuticalsLock up agreement endingCommon stockPrivate placement purchaserLock up periodLock up partiesCitigroup global markets

Certain Stock Options of Lexicon Pharmaceuticals, Inc are subject to a Lock-Up Agreement Ending on 31-JUL-2023

Certain Stock Options of Lexicon Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 31-JUL-2023. These Stock Options will be under lockup for 60 days starting from 1-JUN-2023 to.

Certain stock options of lexicon pharmaceuticals incCitigroup global markets incCertain stock optionsLexicon pharmaceuticalsLock up agreement endingStock optionsPrivate placement purchaserLock up periodLock up partiesCitigroup global markets

Certain Warrants of Lexicon Pharmaceuticals, Inc are subject to a Lock-Up Agreement Ending on 31-JUL-2023

Certain Warrants of Lexicon Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 31-JUL-2023. These Warrants will be under lockup for 60 days starting from 1-JUN-2023 to.

Citigroup global markets incCertain warrants of lexicon pharmaceuticals incCertain warrantsLexicon pharmaceuticalsLock up agreement endingPrivate placement purchaserLock up periodLock up partiesCitigroup global markets

Certain Restricted Stock Units of Lexicon Pharmaceuticals, Inc are subject to a Lock-Up Agreement Ending on 31-JUL-2023

Certain Restricted Stock Units of Lexicon Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 31-JUL-2023. These Restricted Stock Units will be under lockup for 60 days starting from.

Citigroup global markets incCertain restricted stock unitsLexicon pharmaceuticalsLock up agreement endingRestricted stock unitsPrivate placement purchaserLock up periodLock up partiesCitigroup global markets

Lexicon Pharma (LXRX) Prices $125 Million Public Offering and Concurrent Private Placement at $2 60/Each

Lexicon Pharma (LXRX) Prices $125 Million Public Offering and Concurrent Private Placement at $2 60/Each
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerLexicon pharmaceuticals incWall streetFifth amendedRestated certificatePrivate placement purchaserSecurities act